Research Paper Volume 15, Issue 17 pp 8948—8975
Prognostic value and immunological role of CSNK1D in human cancers
Figure 9. Validation of CSNK1D expression in hepatocellular carcinoma based on the ICGC-LIRI-JP cohort. (A) The mRNA expression of CSNK1D in normal and tumor. (B) Comparing the CSNK1D expression in paired normal and tumor. Variation analysis of CSNK1D expression in different Ages (C), Gender (D), stage (E). (F) K-M survival curves of patients with OS. (G, H) The prognostic significance of CSNK1D was analyzed by univariate and multivariate COX analysis. (I) Prognostic evaluation efficacy of CSNK1D by ROC.